Genetic/Molecular Test · 83950
Her-2 Oncoprotein (cancer Related Gene) Measurement
What Medicare pays for 83950, what providers bill, and how the price varies across 3 states, drawn from CMS 2023 claims data.
- $63.12
- Medicare pays
- $389.57
- Providers bill
- 6.2×
- Markup
- #7,381 of 9,297
- Volume rank
The verdict
Her-2 Oncoprotein (cancer Related Gene) Measurement pairs modest national service volume with an above-median markup.
- 21st pct.
- national service volume
- Top 37%
- billed-to-Medicare markup
- 6.2×
- billed vs. Medicare
- $63.12
- Medicare pays, national avg
Volume percentile ranks this code's national service volume against every tracked procedure; markup percentile ranks its billed-to-Medicare ratio the same way. The same two figures drive both the verdict sentence and the chips above.
According to the Centers for Medicare & Medicaid Services (CMS), the 2023 Medicare Physician & Other Practitioners dataset records payments for 9,297 procedure codes billed across 5,426 hospitals in 56 states and territories; see our methodology for how each figure is sourced and computed.
Jurisdiction coverage for this code
56states and territories in the CMS extract
Price Range Across States
What You Might Pay
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
How we estimate these prices
These estimates are based on the RAND Hospital Price Transparency Study (4th Edition, 2024). We map each PlainProcedure category onto a RAND CPT-section bucket (Surgery, Radiology, Pathology and Laboratory, Medicine, Anesthesia, Evaluation and Management) or fall back to the national average when no bucket matches. For Genetic/Molecular Test, the applied ratio is 1.85x Medicare (RAND 2024 Pathology and Laboratory bucket (1.85x) + CMS Medicare baseline). Cash/self-pay estimates blend typical cash discounts (55% of billed charges) with Medicare-based estimates (150% of allowed amounts). These are statistical estimates, not quotes. Contact your insurer or provider for actual costs.
Where this markup sits nationally
Markup (billed ÷ Medicare) across 8,901 procedures with a meaningful Medicare rate
6 Among the most affordable more affordable than 63% of 8,901 procedures
Each bar is a 1-wide band; taller bars hold more procedures. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Physician & Other Practitioners · 2023
What the billed charge breaks down into
$389.57
Prices by State
| State | Medicare Payment | Billed Charge |
|---|---|---|
| California | $63.12 | $392.42 |
| North Carolina | $63.12 | $389.92 |
| Ohio | $63.12 | $390.73 |
What the Data Says About Her-2 Oncoprotein (cancer Related Gene) Measurement
Across 3 states with reporting providers, CPT code 83950 (Her-2 Oncoprotein (cancer Related Gene) Measurement) shows a national average Medicare payment of $63.12 against an average billed charge of $389.57. That gap, a 6.2x markup, or 517% above the Medicare allowed amount, is roughly in line with what most procedures show, chargemaster pricing that no major payer pays in full but that still anchors negotiations.
Genetic/Molecular Test procedures like this one saw 122 services billed to Medicare in 2023 by 10 distinct providers, serving 86 unique beneficiaries. State-level variation is significant: Ohio reports the lowest average payment at $63.12, while California reports the highest at $63.12. At just 0%, this procedure prices remarkably consistently nationwide, GPCI adjustments barely move the needle for this particular code. Applying the RAND 2024 commercial-to-Medicare ratio for this category (1.85x Medicare; RAND 2024 Pathology and Laboratory bucket (1.85x) + CMS Medicare baseline), the estimated commercial insurance price lands near $116.77, with self-pay cash discounts commonly bringing the figure closer to $154.47. Within Genetic/Molecular Test, Her-2 Oncoprotein (cancer Related Gene) Measurement ranks #240 of 298 tracked procedures by national average Medicare payment.
Where this sits in the registry
Her-2 Oncoprotein (cancer Related Gene) Measurement (83950) is a CMS 2023 Part B code. These pages keep the volume map and the markup map separate.
- National volume versus markup on the statistics page, the same two maps as this capsule. Statistics
- Other Genetic/Molecular Test codes, ranked by Medicare payment inside the category. Category
- How volume rank and markup rank are computed. Methodology
- The full procedures listing in volume order. Procedures
Figures here are CMS averages, not a quote for any patient, plan, or visit.
Frequently Asked Questions
Where does Her-2 Oncoprotein (cancer Related Gene) Measurement rank among Medicare procedures?
According to CMS Medicare Part B claims, Her-2 Oncoprotein (cancer Related Gene) Measurement (CPT 83950) ranks #7,381 of 9,297 procedures by national service volume, the same sort as the procedures listing, and #240 of 298 within Genetic/Molecular Test by national average Medicare payment. See /methodology#corpus-placement.
How much does Her-2 Oncoprotein (cancer Related Gene) Measurement cost?
Her-2 Oncoprotein (cancer Related Gene) Measurement (CPT 83950) is priced fairly consistently nationwide: Medicare pays $63.12 on average, and the $63.12-$63.12 state range stays relatively tight. Providers typically bill $389.57.
Why do providers charge more than Medicare pays?
Providers set their own chargemaster rates (billed charges), which are typically much higher than what any insurer pays. Medicare pays a fixed rate based on the procedure code and geographic location. The billed charge is relevant mainly for uninsured patients, who may face prices closer to the submitted charge.
How much does Her-2 Oncoprotein (cancer Related Gene) Measurement cost with insurance?
With commercial insurance, her-2 oncoprotein (cancer related gene) measurement costs an estimated $116.77 on average (range: $81.74-$163.48), a moderate premium over Medicare's $63.12. Without insurance, the estimated cash price is $154.47.
Which state has the lowest cost for Her-2 Oncoprotein (cancer Related Gene) Measurement?
Ohio and California bookend the range for Her-2 Oncoprotein (cancer Related Gene) Measurement, at $63.12 and $63.12 respectively - a relatively tight $0.00 spread nationwide.
How many providers perform Her-2 Oncoprotein (cancer Related Gene) Measurement?
Her-2 Oncoprotein (cancer Related Gene) Measurement is comparatively uncommon: only 10 providers nationally billed Medicare for it in 2023, serving 86 beneficiaries via 122 total services.
What is the billed-to-Medicare markup for Her-2 Oncoprotein (cancer Related Gene) Measurement?
Providers bill 6.2x what Medicare pays for Her-2 Oncoprotein (cancer Related Gene) Measurement - an above-median markup at 517% above the Medicare rate.
Nationwide similar CPT codes
Data-derived peers across the CMS Physician & Other Practitioners extract: nearest national service volume and nearest average Medicare payment. Not clinical substitutes: claim-mass and payment neighborhoods only.
Closest national service volume
Nearest codes with ≥100 services (122 here).
Closest average Medicare payment
Nearest codes with payment ≥ $5 ($63.12 here).
Related Guides
Tips to reduce out-of-pocket costs
Your right to upfront pricing
How Medicare payments work
Decode charges and codes
Why bills exceed actual costs
Geographic pricing factors
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainProcedure is rendered directly from CMS Medicare Physician & Other Practitioners data, no number is typed in by an editor. This page draws directly on CMS Medicare Physician & Other Practitioners data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.